Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

aTYR PHARMA INC Director's Dealing 2021

May 25, 2021

34337_dirs_2021-05-25_6f4e62a1-f65e-4ef0-bea5-543a77eb20a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2021-05-21

Reporting Person: Zaknoen Sara (Director)

More from aTYR PHARMA INC

Interim / Quarterly Report 2026
May 15
Regulatory Filings 2026
May 15
Regulatory Filings 2026
May 11
Regulatory Filings 2026
Mar 26
Major Shareholding Notification 2026
Mar 26
Director's Dealing 2026
Feb 4
Director's Dealing 2026
Feb 4
Director's Dealing 2026
Feb 4
Director's Dealing 2026
Jan 9
Director's Dealing 2026
Jan 9
View all filings →